Tag Archives: National Pharmaceuticals Strategy

The problem with negotiating a price for Kalydeco in Canada is without question a complex one, and not just because of the astronomically high price Vertex wants for this miraculously effective drug. First of all, Vertex seems to hold all … Continue reading →